Skip to main content
. 2020 Oct 14;35(1):91–99. doi: 10.1097/QAD.0000000000002725

Fig. 2.

Proportion of participants with at least 10% weight gain.

Fig. 2

Estimated proportions and 95% confidence interval for treatment group differences (doravirine minus comparator) are from the generalized linear model. DOR, doravirine; DRV+r, ritonavir-boosted darunavir; EFV, efavirenz.